SEC 13F Intelligence

Tri Locum Partners LP / VRNA

Tri Locum Partners LP’s Verona Pharma PLC Position

Does Tri Locum Partners LP own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 216.6K shares worth $20M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$20M
Q2 2025
Shares
216.6K
% of Portfolio
+6.22%
Quarters Held
7
position exited

Position History VRNA

Reported value by quarter
Q1 ’23: $2MQ1 ’23Q2 ’23: $3MQ2 ’23Q3 ’23: $5MQ3 ’23Q4 ’23: $6MQ4 ’23Q3 ’24: $17MQ3 ’24Q4 ’24: $21MQ4 ’24Q2 ’25: $20MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025216.6K$20M+6.22%
Q4 2024454.2K$21M+4.37%
Q3 2024594.0K$17M+4.09%
Q4 2023293.1K$6M+2.66%
Q3 2023318.1K$5M+1.66%
Q2 2023151.2K$3M+1.19%
Q1 202397.8K$2M+0.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of VRNA.